Background: Much of the focus regarding the global pandemic of coronavirus disease of 2019 (COVID-19) has been on the cardiovascular, pulmonary, and hematologic complications. However, neurologic complications have arisen as an increasingly recognized area of morbidity and mortality.
Objective: This brief report summarizes the neurologic complications associated with COVID-19 with an emphasis on the emergency medicine clinician.
Discussion: COVID-19 has infected over 3.5 million people and killed over 240,000 people worldwide. While pulmonary complications are profound, the neurologic system is also significantly impacted, with complications including acute cerebrovascular events, encephalitis, Guillain-Barré syndrome, acute necrotizing hemorrhagic encephalopathy, and hemophagocytic lymphohistiocytosis. Additionally, patients on immunosuppressive medications for pre-existing neurologic issues are at an increased risk for complications with COVID-19 infection, and many of the currently proposed COVID-19 therapies can interact with these medications.
Conclusions: When caring for COVID-19 patients, emergency medicine clinicians should be aware of the neurologic complications from COVID-19.
Keywords: COVID-19; Cerebrovascular disease; Coronavirus; Encephalopathy; HLH; Infectious disease; Neurologic.
© 2020 Published by Elsevier Inc.
Cardiovascular complications in COVID-19.Am J Emerg Med. 2020 Apr 18:S0735-6757(20)30277-1. doi: 10.1016/j.ajem.2020.04.048. Online ahead of print. Am J Emerg Med. 2020. PMID: 32317203 Free PMC article. Review.
Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors.J Am Heart Assoc. 2020 Apr 29:e017013. doi: 10.1161/JAHA.120.017013. Online ahead of print. J Am Heart Assoc. 2020. PMID: 32347144
Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis.J Clin Neurosci. 2020 Apr 16:S0967-5868(20)30681-0. doi: 10.1016/j.jocn.2020.04.054. Online ahead of print. J Clin Neurosci. 2020. PMID: 32307298 Free PMC article.
Coronavirus Disease (COVID-19): A primer for emergency physicians.Am J Emerg Med. 2020 Mar 24:S0735-6757(20)30178-9. doi: 10.1016/j.ajem.2020.03.036. Online ahead of print. Am J Emerg Med. 2020. PMID: 32265065 Free PMC article.
Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.Clin Rheumatol. 2020 Apr 10:1-8. doi: 10.1007/s10067-020-05073-9. Online ahead of print. Clin Rheumatol. 2020. PMID: 32277367 Free PMC article. Review.
- World Health Organization Coronavirus disease (COVID-19) situation report 102. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
- CDC; Cases in the U.S. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html
- World Health Organization Coronavirus disease (COVID-19): situation report 105. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
- Filatov A., Sharma P., Hindi F., Espinosa P.S. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020;12(3) doi: 10.7759/cureus.7352. - DOI
- Sellner J., Taba P., Öztürk S., Helbok R. The need for neurologists in the care of COVID-19 patients. Eur J Neurol. 2020 doi: 10.1111/ene.14257. April. ene.14257. - DOI